Insider Transactions in Q2 2023 at Core Laboratories N V (CLB)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 01
2023
|
Eeuwijk Monique Van Dijken Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,485
+24.27%
|
-
|
|
Apr 01
2023
|
Kwaku Temeng Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,485
+35.9%
|
-
|
|
Apr 01
2023
|
Michael Straughen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,485
+22.41%
|
-
|
|
Apr 01
2023
|
Michael Straughen Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,524
-13.29%
|
$55,528
$22.05 P/Share
|
|
Apr 01
2023
|
Harvey Robert Klingensmith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,485
+17.3%
|
-
|
|
Apr 01
2023
|
Katherine Murray Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,485
+50.0%
|
-
|
|
Apr 01
2023
|
Martha Z. Carnes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,485
+15.2%
|
-
|